Long-Acting Reversible Contraception: An Important Solution to Reduce Unintended Pregnancy

Click to Register
1.0 AMA PRA Category 1 Credit

Saturday, October 22, 2016
Noon – 1:30 PM

Program Location

Grand Hyatt New York
Room: Alvin/Carnegie, Conference Level
109 E. 42nd Street
New York, New York

Program Overview

Despite the availability of numerous contraceptive options, almost half of all pregnancies in the United States are unintended, creating a substantial negative health and socioeconomic burden on women and their families. The most commonly used contraceptives are dependent on adherence and “perfect use” to be efficacious, while long-acting reversible contraceptives (LARCs) offer the lowest failure rates primarily because they are user-independent. Greater use of the highly effective LARCs may provide one solution to the persistent problem of unplanned pregnancies and improve women’s and children’s health.

This event is neither sponsored nor endorsed by The American Congress of Obstetricians and Gynecologists (ACOG).

Anita Nelson, MD (Program Chair)
Professor and Chair
Obstetrics and Gynecology
Western University of Health Sciences
Professor Emeritus
David Geffen School of Medicine at UCLA
Los Angeles, California
Andrew M. Kaunitz, MD
Professor and Associate Chair
Department of Obstetrics and Gynecology
University of Florida College of Medicine--Jacksonville
Jacksonville, Florida



Click to Register
1.0 AMA PRA Category 1 Credit


Noon – 12:30 PM
On-site Check-in & Lunch

12:30 PM – 1:30 PM
CME Symposium

Educational Objectives

Upon completion of this activity, participants will be better able to:

  1. List and compare the benefits and limitations with regard to efficacy and safety of long-acting reversible contraceptives
  2. Describe the appropriateness of long-acting reversible contraceptives for women at risk for unintended pregnancy
  3. Employ a strong patient-provider collaborative approach to caring for sexually active female patients that includes patient education and shared decision-making regarding long-acting reversible contraceptives
Target Audience

This activity has been designed to meet the educational needs of health care professionals who provide care for women during their reproductive life.

Financial Support

This live activity is supported by an independent educational grant from Teva Pharmaceuticals.

Provider Information

This live educational activity is jointly provided by the Elsevier Office of Continuing Medical Education and Miller Medical Communications, LLC.

CME Credits (Physicians)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Elsevier Office of Continuing Medical Education and Miller Medical Communications, LLC. The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information

There is no registration fee for attending this symposium.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc) or questions. Please contact Miller Medical Communications, LLC prior to the live event at Kerri.Leonard@millermeded.com or 212-661-7400image ext. 3.

Disclosure of Unlabeled Use:  This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, Miller Medical Communications, LLC, and Teva Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Group visibility: 
Public - accessible to all site users